Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander? - Wikidata - awgldk - TriplyDB

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

http://www.wikidata.org/entity/Q34882979

about

Peripheral blood biomarkers in idiopathic pulmonary fibrosis Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43 Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function Altered miRNA expression in pulmonary sarcoidosis.Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes.A review of current and novel therapies for idiopathic pulmonary fibrosis Angiogenesis in chronic lung disease Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease.Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis.Transforming growth factor-beta 1 in humidifier disinfectant-associated children's interstitial lung disease.Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis.Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series).VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease.Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis.

P2860

Q27000707-2415B144-767B-4722-BC65-06A0E1E3C8E5 Q30426561-24307444-4B3B-42FA-AEB8-228EB031C7FB Q33732623-CBC49467-85BB-4B17-B707-D506769EA1D9 Q34488513-895F8C32-3638-4A97-8A8A-BE0855D9633C Q35179145-F5192811-CBA5-4174-8560-CB0FA5F81C8D Q35894467-97A70B80-60A4-4FE7-88B2-41FF94722D4A Q36464112-2F86CBB0-9097-4F12-A08F-87021B1D22CC Q36542274-1F2A439F-B318-4068-BD0F-FA6C9CED0524 Q36758867-B7F19027-F7C9-42E8-955A-744BA57E26D6 Q36960794-0A30A571-F180-4710-ADB9-3BBE39485F2C Q37082574-67D302A6-BDFB-465F-9D16-6A1A5BD07C26 Q38181043-8E1D048C-FEF3-48EF-9756-54BE3BA987C5 Q41641787-2EC1236F-FDB8-4AB4-8F50-8F1903CF0964 Q43153864-A82FB4B0-A2C3-4A30-8F50-C2F3BB793518 Q47117383-BEF46E4C-F6FA-4E7E-B1F8-475840F0BDCA Q52309706-9429670B-F378-4A34-B06A-5408398E14F9 Q54446707-5C0CEF62-7BE0-40A1-A87F-36145A83A7F2

P2860

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

http://www.wikidata.org/entity/Q34882979

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@ast

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@en

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@nl

type

label

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@ast

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@en

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@nl

prefLabel

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@ast

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@en

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@nl

P1433

Q34882979-9427F5CB-834C-4C8E-9A62-BC201BCC494C

P1476

Q34882979-D2E0129F-1E36-4EC5-8B65-F30D1298298C

P2093

Q34882979-1F999A0C-4086-4BD4-9A3F-9025C06985EA

Q34882979-8130246D-4E51-4E4E-85A0-855027112E65

P275

Q34882979-6C12C662-73FD-4711-9BCF-773AECFE2883

P2860

Q34882979-00765569-78DA-40D4-A4AF-094437F79451

Q34882979-04E74942-2DB6-40D7-8BBF-B06D22D6A924

Q34882979-0FB49121-687B-4E91-B0A0-2C9E80F264AD

Q34882979-12D7F77D-AC88-4AD6-8CB9-C2313E04E81D

Q34882979-1E31A078-C21C-4D01-A583-50B7D7C85F68

Q34882979-1EE950BA-E56B-4331-8E78-0A326B40B3F8

Q34882979-1FC0222A-BCCE-4CBE-8B82-B6F53C1F3453

Q34882979-20214418-F091-4EB5-A0FF-C5ACFA8F8B76

Q34882979-21A7AF99-E8EF-4675-BB00-FEBDE5909A30

Q34882979-22EF7953-03A8-4609-99A7-C0E865981789

P2888

Q34882979-756A80A6-02F5-45F4-B18E-A9A2664C4C5D

P304

Q34882979-4F078D0A-21EB-454A-B4E4-8FCBD84AC185

P31

Q34882979-5bc04c72-cb03-4eb8-94f5-04abce415ab5

Q34882979-A69EF588-464A-4473-ADE9-6C3251CBF5F5

P356

Q34882979-6893B1E3-8F5B-45B0-96EB-A6859F45D046

P478

Q34882979-D6B7F408-6B44-47C8-BFAA-2C799E203931

P50

Q34882979-24180E59-5C31-4B62-8DF1-712416701521

Q34882979-C2B0FB1A-CF6F-436D-8828-1B7891BBE8F7

P5008

Q34882979-9AC9C8BE-F76A-4B9C-9C21-4553FE0EB39A

P577

Q34882979-1D6F8D45-0BC1-4391-B065-58845F74FDB2

P5875

Q34882979-4A0FB56E-78DE-46EE-AA65-6DD56C9539BE

P6179

Q34882979-25A248F9-B0AF-4A5C-AB72-5E8E69A5FD08

P698

Q34882979-658B6327-ED08-443D-9AF0-BB2821AC2936

P921

Q34882979-28A88B00-1B2B-4E6B-912F-69A71E1E2A5B

Q34882979-52103B10-0589-4FFB-ABC9-65BFB6BFCBD6

Q34882979-915513B5-1C88-49A7-B2FB-202174C7A160

Q34882979-DE79E8B3-9712-4C3B-AFAF-CFA239C2A3CD

P932

Q34882979-AD361F83-192C-4FE3-B701-0EC3567AFD87

P356

P1433

Respiratory Research

P1476

Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

@en

P2093

Argyris Tzouvelekis

http://www.w3.org/2001/XMLSchema#string

Stavros Anevlavis

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Regulation of pulmonary fibrosis by chemokine receptor CXCR3

Oxygen-regulated transcription factors and their role in pulmonary disease

Application of microarray technology in pulmonary diseases

Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis

Serum biomarkers in interstitial lung diseases

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis

Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas

Chemokines--chemotactic cytokines that mediate inflammation

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

P2888

P304

82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1465-9921-7-82

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Demosthenes Bouros

Demosthenes Bouros

P5008

P577

2006-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7057922

http://www.w3.org/2001/XMLSchema#string

P6179

1052450890

http://www.w3.org/2001/XMLSchema#string

P698

16725031

http://www.w3.org/2001/XMLSchema#string

P921

interstitial lung disease

Anagraw amesgunef

P932

1524948

http://www.w3.org/2001/XMLSchema#string